Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Trends in Immunotherapy (IO) Use and Survival Among Patients With High‐Incidence Stage IV Cancers Across the United States

Journal of Surgical Oncology(2025)10.1002/jso.28084Source: DataRank Database

Trends in Immunotherapy (IO) Use and Survival Among Patients With High‐Incidence Stage IV Cancers Across the United States is a research paper published in Journal of Surgical Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.59)OA: hybridTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Lauren M. Janczewski ORCID,Gladys M. Rodriguez ORCID,Jeffrey D. Wayne ORCID,David J. Bentrem ORCID,Samantha Warwar

Live enrichment

PubMed:39806540 PMC:PMC12186102 OpenAlex:https://openalex.org/W4406380302

NCI NIH HHS

Grant: R38 CA245095

This work is supported by the National Institutes of Health training.

FWCI

1.59

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jso.28084

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jso.28084

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.28084

journalhttps://doi.org/10.1002/jso.28084

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39806540

Fields of Study

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsHumansUnited StatesFemaleMaleNeoplasmsIncidenceSurvival RateNeoplasm StagingAgedImmunotherapyMiddle AgedFollow-Up Studies

MeSH Terms

AgedFemaleFollow-Up StudiesHumansImmunotherapyMaleMiddle AgedNeoplasm StagingNeoplasmsUnited StatesIncidenceSurvival Rate

Keywords

MedicineIncidence (geometry)Stage (stratigraphy)ImmunotherapyOncologyInternal medicineDemographyCancerMelanomaNeoplasms By SiteAdvanced Cancer TherapySurvival Disparities

Sustainable Development Goals

SDG 0: Good health and well-being